Spike seen in prices of several Rx pain drugs

Share this article:

Dozens of prescription painkillers are up to 15 percent more costly since last year's withdrawal of Vioxx, according to a report from Consumers Union.
The Consumer Reports Best Buy Drugs report says price increases were seen among 36 pain drugs, along with growth in prescribing volume among NSAIDs (nonsteroidal anti-inflammatory drugs). Among them, prices for prescription strength Motrin, from Johnson & Johnson's McNeil-PPC, climbed 13.3 percent and Boehringer Ingelheim's Mobic, marketed in the U.S. by Abbott, jumped 10.6 percent.
Based on data from NDCHealth, the report also says 17 drugs dropped in price, and 10 remained flat.OTC medicines were not included. Merck pulled Vioxx in September after studies linked the COX-2 drug to heart problems.

 

Share this article:

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.